Rizatriptan Alvogen (Rizatriptan Portfarma) Munndreifitafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

rizatriptan alvogen (rizatriptan portfarma) munndreifitafla 10 mg

alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 10 mg

Rizatriptan Alvogen (Rizatriptan Portfarma) Munndreifitafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

rizatriptan alvogen (rizatriptan portfarma) munndreifitafla 5 mg

alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 5 mg

Blincyto Evrópusambandið - íslenska - EMA (European Medicines Agency)

blincyto

amgen europe b.v. - blinatumomab - forvarnarfrumuæxli-eitilfrumuhvítblæði - Æxlishemjandi lyf - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Gliolan Evrópusambandið - íslenska - EMA (European Medicines Agency)

gliolan

photonamic gmbh & co. kg - 5-amínólevúlínsýru hýdróklóríð - glioma - Æxlishemjandi lyf - gliolan er ætlað fullorðnum sjúklingum til að visualize illkynja vefjum meðan á aðgerð stendur fyrir illkynja glioma (world health organization iii og iv).

Prialt Evrópusambandið - íslenska - EMA (European Medicines Agency)

prialt

esteve pharmaceuticals gmbh - zícónótíð - injections, spinal; pain - verkjalyf - zícónótíð er ætlað til meðferðar við alvarlegum langvarandi sársauka hjá sjúklingum sem þarfnast verkjastillingar.

Omnipaque Stungulyf, lausn 350 mg J/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omnipaque stungulyf, lausn 350 mg j/ml

ge healthcare as - iohexolum inn - stungulyf, lausn - 350 mg j/ml

Omnipaque Stungulyf, lausn 300 mg J/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omnipaque stungulyf, lausn 300 mg j/ml

ge healthcare as - iohexolum inn - stungulyf, lausn - 300 mg j/ml

Omnipaque Stungulyf, lausn 180 mg J/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omnipaque stungulyf, lausn 180 mg j/ml

ge healthcare as - iohexolum inn - stungulyf, lausn - 180 mg j/ml

Omnipaque Stungulyf, lausn 140 mg J/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omnipaque stungulyf, lausn 140 mg j/ml

ge healthcare as - iohexolum inn - stungulyf, lausn - 140 mg j/ml

Lyrica Evrópusambandið - íslenska - EMA (European Medicines Agency)

lyrica

upjohn eesv - pregabalín - epilepsy; anxiety disorders; neuralgia - antiepileptics, , Önnur antiepileptics - taugakvillaverkur painlyrica er ætlað fyrir meðferð af útlimum og central taugaverkir í fullorðnir. epilepsylyrica er fram eins og venjulega meðferð í fullorðnir með hluta flog með eða án efri almenn ákvörðun er tekin. almenn kvíða disorderlyrica er ætlað fyrir meðferð almenn kvíða (himnum) hjá fullorðnum.